News

Springtime in Washington, D.C., is synonymous with cherry blossom season, when the thousands of cherry blossom trees gifted ...
US biotech Wayfinder Biosciences has entered a research collaboration with Japanese drugmaker Daiichi Sankyo (TSE: 4568) to ...
Daiichi Sankyo used the National Cherry Blossom Festival in Washington, D.C. as a platform to raise awareness about its oncology goals.
The EC has approved Daiichi Sankyo and AstraZeneca’s Enhertu for use as a single agent to treat adults with certain breast ...
Pharmaceutical stocks saw strong gains on Thursday after US President Donald Trump announced that pharmaceuticals would be exempt from the latest round of reciprocal tariffs on global imports. The ...
Drugmakers have said they’re still unclear about whether Trump will impose tariffs on finished products or on active ...
Datroway (datopotamab deruxtecan) has been approved in the European Union (EU) for the treatment of adult patients with ...
Stocks in drugmakers sold off globally after President Trump said tariffs on pharmaceutical imports will be unveiled shortly, ...
A wild ride in an escalating trade war has torn at Big Pharma’s shares while global markets flag in the back-and-forth winds.